Natural aldehyde functionalized full-biomass aerogel and preparation method thereof
By using chitosan and whey protein amyloid fiber aerogel, combined with jenipine crosslinking and natural aldehyde grafting technology, the contamination problem of PAEs in food is solved, achieving efficient removal effect, providing a A highly secure and efficient solution.
Patent Information
- Application Number
- CN202411082357.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-08
AI Technical Summary
Phthalate is harmful to human health and is easy to enter food. The existing removal technology is low in efficiency and requires the development of efficient adsorption materials.
Chitosan and whey protein isolate amyloid fibers were used as adsorption materials, and aerogels with high mechanical properties and high affinity were prepared by cross-linking of genipine and grafting of natural aldehydes.
The prepared natural aldehyde functionalized whole biomass aerogel has high safety and high affinity, and has significantly improved the removal efficiency of PAEs, making it suitable for the food industry.
Smart Images

Figure CN119034627A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of aerogels and relates to a natural aldehyde functionalized all-biomass aerogel and a preparation method thereof. Background Art
[0002] Plasticizer is a processing aid widely used in polymer materials to improve their processability and plasticity. Phthalates (PAEs) are the most commonly used plasticizers (>85%), with an annual global production of 4.9 million tons. However, PAEs are bound to the polymer matrix through non-covalent bonds and are easily migrated to the environment, causing environmental pollution. Many studies have shown that PAEs have many hazards to human health. In addition, PAEs can enter food through various pathways, such as food raw material contamination caused by environmental pollution, food processing and food plastic packaging pollution, and illegal artificial additions. Therefore, PAEs have received increasing research attention worldwide. Previous studies have mainly focused on the toxicity and detection of PAEs, while the development of efficient PAEs removal technology has become a research hotspot in recent years.
[0003] Adsorption, advanced oxidation processes and biological treatment are effective technologies for removing PAEs. Among various treatment methods, adsorption is superior to other methods due to its clean operation. In addition, industrial scale-up of the adsorption process does not require large plants. Therefore, compared with advanced oxidation processes and biological treatment, non-destructive technologies such as adsorption are more attractive from the perspectives of environmental protection and economic benefits.
[0004] Aerogels are a class of three-dimensional materials whose open, porous, air-filled structures have low density, high porosity, and large specific surface area, making them very suitable for use as adsorbents. Considering economic factors and safety issues, biopolymer composite aerogels (polysaccharides and proteins) have become ideal candidates for water purification, mainly due to their non-toxic, low-cost, abundant reserves, wide sources, biodegradability, and unique properties such as biocompatibility and availability. Summary of the invention
[0005] Technical issues
[0006] Phthalates have many harmful effects on human health, but due to their wide range of applications, they can enter food processing through various channels, causing immeasurable impacts. Adsorption is an excellent solution because of its convenience and high efficiency, so it is necessary to develop an adsorption material suitable for removing phthalates.
[0007] Technical Solution
[0008] The present invention selects chitosan and whey protein isolate amyloid fibers as adsorption materials, and produces aerogels with excellent mechanical properties, structural stability and high PAEs affinity through a preparation process that is simple and has no safety risks.
[0009] The present invention also uses the natural biocrosslinking agent genipin to prepare a chitosan-whey protein isolate amyloid fiber covalent network to improve the mechanical properties and structural stability of the aerogel while ensuring the safety of the aerogel. In addition, natural aldehydes are grafted by Schiff base covalent action to improve the mechanical properties of the chitosan-whey protein isolate amyloid fiber composite aerogel and its affinity for PAEs. In order to obtain a satisfactory removal efficiency, the effects of two aromatic aldehydes and three fatty aldehydes with different chain lengths or saturations on improving the removal efficiency of PAEs were studied.
[0010] The present invention provides a method for preparing a natural aldehyde functionalized all-biomass aerogel, comprising the following steps:
[0011] (1) dispersing chitosan in an amyloid fiber solution and stirring to obtain a uniform mixed solution;
[0012] (2) adding genipin as a cross-linking agent to the mixed solution obtained in step (1), heating and stirring for a period of time to obtain an aerogel precursor solution, and allowing it to stand for cross-linking to obtain a hydrogel;
[0013] (3) freezing the hydrogel obtained in step (2), and then freeze-drying to obtain an aerogel;
[0014] (4) The aerogel obtained in step (3) is immersed in a natural aldehyde solution for grafting modification, then taken out for rinsing, and then dried to obtain the aldehyde functionalized aerogel.
[0015] In one embodiment of the present invention, the method for preparing the amyloid fiber solution in step (1) comprises the following steps:
[0016] S1. Purification of whey protein isolate: adding protein powder to water, stirring to obtain a protein dispersion, adjusting the pH of the protein dispersion to 4-5, centrifuging to obtain a supernatant, passing the supernatant through a 0.4-0.5 μm water filter membrane, and freeze-drying the filtrate to obtain purified protein;
[0017] S2. Preparation of amyloid fiber solution: taking purified protein powder and dispersing it in water, stirring the obtained protein solution, then adjusting the pH of the protein solution to 2-2.5, and then stirring to obtain a whey protein isolate amyloid fiber solution.
[0018] Furthermore, the protein powder in step S1 is one of soy protein isolate, whey protein isolate, and lysozyme.
[0019] Preferably, the protein powder in step S1 is whey protein isolate.
[0020] Furthermore, the protein powder concentration of the protein dispersion in step S1 is 5 to 15 wt %.
[0021] Furthermore, in step S1, the stirring is performed at a speed of 100 to 1000 rpm for 8 to 12 hours.
[0022] Furthermore, the centrifugation in step S1 is performed at 8000-10000×g for 20-30 minutes.
[0023] Furthermore, the concentration of the purified protein powder in the protein solution in step S2 is 1 to 5 wt %.
[0024] Furthermore, in step S2, the stirring is performed at 70 to 90° C. at a speed of 100 to 1000 rpm for 8 to 12 hours.
[0025] In one embodiment of the present invention, the concentration of amyloid fibers in the amyloid fiber solution in step (1) is 1-1.25% (w / v).
[0026] In one embodiment of the present invention, the amyloid fiber solution in step (1) further contains 1-2 wt % of acetic acid.
[0027] In one embodiment of the present invention, in step (1), the mass ratio of chitosan to amyloid fibers is 1.5-2.5:1.
[0028] In one embodiment of the present invention, in step (2), genipin is added in the form of a genipin ethanol solution; the concentration of genipin in the genipin ethanol solution is 5 to 15% (w / v).
[0029] In one embodiment of the present invention, the ratio of the mass of genipin added in step (2) to the mass of chitosan added in step (1) is 1:15-25.
[0030] In one embodiment of the present invention, the heating temperature in step (2) is 45-55°C.
[0031] In one embodiment of the present invention, the heating time in step (2) is 15-30 minutes.
[0032] In one embodiment of the present invention, the temperature of static cross-linking in step (2) is 20-25°C.
[0033] In one embodiment of the present invention, the static cross-linking time in step (2) is 24-32 hours.
[0034] In one embodiment of the present invention, the freezing temperature in step (3) is -20 to -10°C and the freezing time is 15 to 30 hours.
[0035] In one embodiment of the present invention, the freeze-drying pressure in step (3) is 1-10 Pa, the temperature is -50 to -60°C, and the time is 60-72 h.
[0036] In one embodiment of the present invention, the natural aldehyde in step (4) includes one or more of citral, citronellal, cinnamaldehyde, p-anisaldehyde, and trans-2-hexenal.
[0037] Preferably, the natural aldehyde in step (4) is citral.
[0038] In one embodiment of the present invention, the solvent of the natural aldehyde solution in step (4) is anhydrous ethanol; and the concentration of the natural aldehyde in the natural aldehyde solution is 1.5-1.75% (w / v).
[0039] In one embodiment of the present invention, the temperature of the grafting modification in step (4) is 60-70° C. and the time is 10-12 hours.
[0040] In one embodiment of the present invention, the elution in step (4) is performed using anhydrous ethanol.
[0041] The invention provides natural aldehyde functionalized all-biomass aerogel prepared according to the method.
[0042] The natural aldehyde functionalized all-biomass aerogel provided by the present invention is applied in the fields of environmental protection or food processing.
[0043] Compared with the prior art, the present invention has the following beneficial effects:
[0044] 1. The present invention uses a natural cross-linking agent to prepare chitosan-amyloid fiber covalent network aerogel for the first time, which has excellent mechanical properties, structural stability and high safety.
[0045] 2. The present invention produces aerogels with excellent mechanical properties, structural stability and high affinity to DBP through a simple preparation process. The gel materials used are chitosan and whey protein isolate, which have the advantages of being non-toxic, cheap, abundant in reserves, environmentally friendly, and biodegradable. Natural aldehydes are used as modifiers, which have the advantages of being non-toxic and antibacterial, and have great application value for industrial production.
[0046] 3. The aerogel prepared by the present invention has high safety and high affinity to PAEs, and can be applied to PAEs removal, especially for the food industry. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1: Stress-strain curves of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 1-5.
[0048] Figure 2 : Diagram of dibutyl phthalate removal efficiency of chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 1-5.
[0049] Figure 3 : Appearance of chitosan-amyloid fiber aerogel in Example 5.
[0050] Figure 4 : Scanning electron micrographs of chitosan-amyloid fiber aerogels in Comparative Example 1 and Example 5.
[0051] Figure 5 : Dibutyl phthalate removal efficiency (a) and scanning electron microscopy (b) of chitosan-amyloid fiber aerogel in Comparative Example 2 and Example 5.
[0052] Figure 6 : Graph showing the amount of citral grafted into chitosan-amyloid fiber aerogels in Examples 6-10.
[0053] Figure 7 : Stress-strain curves of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 6-10.
[0054] Figure 8 : Water contact angle diagram of chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10.
[0055] Fig. 9 : Expansion rate diagram of chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10.
[0056] Fig.10 : Thermal stability diagram of chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10.
[0057] Fig.11 : Diagram of dibutyl phthalate removal efficiency of chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10.
[0058] Fig.12 : Graph showing the removal efficiency of various phthalates by chitosan-amyloid fiber aerogel in Example 8. DETAILED DESCRIPTION
[0059] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention is clearly and completely described below in conjunction with specific embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0060] In the following embodiments, the preparation method of whey protein isolate amyloid fibers is as follows:
[0061] First, whey protein isolate is purified. Simply put, 10g of whey protein isolate powder is added to 100mL of deionized water. Then stir overnight with a magnetic stirrer at 600rpm to completely hydrate the protein. The pH of the resulting protein dispersion is then adjusted to 4.75 and centrifuged at 10,000×g for 30 minutes to remove any insoluble matter. The supernatant is then passed through a 0.45μm water filter to remove residual insoluble protein. Finally, the purified whey protein isolate is obtained by vacuum freeze drying.
[0062] For the preparation of amyloid fibers, 2 g of purified whey protein isolate powder was dispersed in 100 mL of deionized water and stirred overnight to fully hydrate the protein. The pH of the resulting protein solution was adjusted to 2.0, and then stirred at 300 rpm for 8 h in a 90 ° C water bath to promote protein fiber formation. Finally, it was cooled in an ice water bath for at least 30 min to terminate the fibrillation reaction and obtain a whey protein isolate amyloid fiber solution (2%, w / v).
[0063] Example 1
[0064] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0065] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0066] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0067] Step 4: The aerogel obtained in step 3 was immersed in a 1.5% (w / v) cinnamaldehyde ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain cinnamaldehyde functionalized chitosan-whey protein isolate amyloid fiber aerogel.
[0068] Example 2
[0069] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0070] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0071] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0072] Step 4: The aerogel obtained in step 3 was immersed in a 1.5% (w / v) p-anisaldehyde ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain p-anisaldehyde functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0073] Example 3
[0074] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0075] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0076] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0077] Step 4: The aerogel obtained in step 3 was immersed in a 1.5% (w / v) trans-2-hexenal ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain trans-2-hexenal functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0078] Example 4
[0079] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0080] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0081] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0082] Step 4: The aerogel obtained in step 3 was immersed in a 1.5% (w / v) citronellal ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain citronellal functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0083] Example 5
[0084] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0085] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0086] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0087] Step 4: Soak the aerogel obtained in step 3 in a 1.5% (w / v) citral ethanol solution, keep it at 65°C for 10 hours for grafting modification, then take it out and rinse it thoroughly with anhydrous ethanol, and dry it in a fume hood for 24 hours to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0088] Comparative Example 1
[0089] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0090] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0091] Step 3: The hydrogel obtained in step 2 is placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain an aerogel without natural aldehyde grafting.
[0092] Comparative Example 2
[0093] Step 1: Disperse 1.2 g of chitosan in 40 mL of deionized water (containing 1% acetic acid) and stir until completely dissolved to obtain a uniform mixed solution.
[0094] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0095] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0096] Step 4: The aerogel obtained in step 3 was immersed in a 1.5% (w / v) citral ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain aldehyde-functionalized chitosan aerogel.
[0097] Testing process:
[0098] 0.8 g of the aerogel samples of Comparative Example 1 and Examples 1-5 were respectively placed in 100 mL of DBP solution (2 mg / L), and then placed on a shaker and shaken at 120 rpm at 25° C. until adsorption equilibrium was reached. The aerogels were then taken out and the residual concentration of DBP was detected by gas chromatography-mass spectrometry.
[0099] Test results:
[0100] Figure 1 The stress-strain curves of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 1-5 are shown. It can be seen that all aerogels have good mechanical properties. The maximum compressive strength of the aerogels in Comparative Example 1 that are not modified with aldehyde can still reach 595Kpa, which is attributed to their covalent gel network. After the aerogels in Examples 1-5 are modified with aldehyde, their mechanical properties are further improved, and higher stress is shown under the same strain, indicating an increase in mechanical strength. Among them, the aerogels in Example 5 show the best mechanical properties, indicating that citral grafting is an effective strategy for improving chitosan-amyloid fiber aerogels, which may be attributed to its good compatibility with the material matrix.
[0101] Figure 2 The DBP removal efficiency of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 1-5 is shown. It can be seen that the DBP removal efficiency of chitosan-amyloid fiber aerogels in Comparative Example 1 is the lowest, which may be attributed to its lower DBP affinity. After the aerogels in Examples 1-5 are grafted with natural aldehydes, the removal efficiency of DBP is significantly improved, which is mainly attributed to the hydrophobic interaction and Π-Π stacking between the natural aldehyde molecules and DBP. In addition, compared with Examples 1-2, the aerogels in Examples 3-5 have higher DBP removal capabilities, indicating that the strong hydrophobic interaction between the linear aldehyde and DBP is the key to high removal efficiency, rather than the Π-Π stacking of aromatic aldehydes. The increasing trend of aerogel removal efficiency in Examples 3-5 indicates that the increase in the length of the linear aldehyde chain and the increase in the degree of unsaturation may also promote the adsorption of DBP.
[0102] Figure 3 The appearance of the chitosan-amyloid fiber aerogel in Example 5 is shown. It can be seen that the prepared aerogel can stand stably on the dandelion without destroying its structure, indicating that it has the characteristics of low density and high porosity and is suitable for application in the adsorption field.
[0103] Figure 4Scanning electron micrographs of the chitosan-amyloid fiber aerogels in Comparative Example 1 and Example 5 are shown, and it can be seen that the aerogel in Comparative Example 1 has randomly distributed irregular macropores and a honeycomb macroporous structure, which is caused by large ice crystals formed during the freezing process at -18°C. The porous structure provides abundant active sites for the adsorption of pollutant molecules. The aerogel in Example 5 maintains the original honeycomb macroporous structure after citral grafting, indicating that the aerogel has good structural stability and can resist environmental drying during the modification process. In addition, compared with the aerogel in Comparative Example 1, the network structure of the aerogel in Example 5 becomes dense, which is conducive to adsorption applications. More importantly, the pore wall of the aerogel in Example 5 is thicker than that in Comparative Example 1, indicating that the grafting of citral increases the thickness of the aerogel pore wall, which can improve the mechanical properties and stability of the aerogel by creating a stronger porous structure.
[0104] Figure 5 The DBP removal efficiency (a) and scanning electron microscope image (b) of chitosan-amyloid fiber aerogel in Comparative Example 2 and Example 5 are shown. Figure 5 It can be seen from a that the chitosan aerogel in Comparative Example 2 has a lower removal efficiency than that in Example 5, indicating the positive role of amyloid fibers in DBP removal. Figure 5 b It can be seen that the aerogel of Comparative Example 2 has a pore structure similar to that of the aerogel of Example 5, but its pore wall surface is smooth and no fibrous material is attached, indicating that amyloid fibers are attached to the surface of the aerogel. Increasing the roughness and providing a large number of adsorption sites are the keys to improving the removal efficiency.
[0105] Example 6
[0106] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0107] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0108] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0109] Step 4: The aerogel obtained in step 3 was immersed in a 0.5% (w / v) citral ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0110] Example 7
[0111] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0112] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0113] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0114] Step 4: Soak the aerogel obtained in step 3 in a 1.0% (w / v) citral ethanol solution, keep it at 65°C for 10 hours for grafting modification, then take it out and rinse it thoroughly with anhydrous ethanol, and dry it in a fume hood for 24 hours to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0115] Example 8
[0116] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0117] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0118] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0119] Step 4: Soak the aerogel obtained in step 3 in a 1.5% (w / v) citral ethanol solution, keep it at 65°C for 10 hours for grafting modification, then take it out and rinse it thoroughly with anhydrous ethanol, and dry it in a fume hood for 24 hours to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0120] Example 9
[0121] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0122] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0123] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0124] Step 4: The aerogel obtained in step 3 was immersed in a 2.0% (w / v) citral ethanol solution, kept at 65°C for 10 h for grafting modification, then taken out and rinsed thoroughly with anhydrous ethanol, and dried in a fume hood for 24 h to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0125] Example 10
[0126] Step 1: Disperse 0.8 g of chitosan in 40 mL of 1% (w / v) whey protein isolate amyloid fiber solution (containing 1% acetic acid), and stir until completely dissolved to obtain a uniform mixed solution.
[0127] Step 2: Add 0.4 mL of genipin ethanol solution (10% (w / v)) as a crosslinker to the mixed solution obtained in step 1, stir at 50°C, 300 rpm for 20 min to obtain a uniform aerogel precursor solution, and let it stand at room temperature for 24 h to promote crosslinking to obtain a hydrogel.
[0128] Step 3: The hydrogel obtained in step 2 was placed in a -18°C refrigerator and frozen for 24 hours, and vacuum freeze-dried for 60 hours to obtain aerogel.
[0129] Step 4: Soak the aerogel obtained in step 3 in a 3.0% (w / v) citral ethanol solution, keep it at 65°C for 10 hours for grafting modification, then take it out and rinse it thoroughly with anhydrous ethanol, and dry it in a fume hood for 24 hours to obtain citral functionalized chitosan-whey isolate protein amyloid fiber aerogel.
[0130] Testing process:
[0131] 0.8 g of the aerogel samples of Comparative Example 1 and Examples 6-10 were respectively placed in 100 mL PAEs solution (2 mg / L), and then placed on a shaker and shaken at 120 rpm at 25° C. until adsorption equilibrium was reached. The aerogels were then taken out and the residual concentration of PAEs was detected by gas chromatography-mass spectrometry.
[0132] Test results:
[0133] Figure 6 The citral grafting amount of the chitosan-amyloid fiber aerogel in Examples 6-10 is shown. It can be seen that as the citral concentration increases, the citral grafting amount increases linearly, reaching a maximum of 0.31 g / g, indicating that the surface of the chitosan-amyloid fiber aerogel contains a large number of active amino groups as citral grafting sites.
[0134] Figure 7 The stress-strain curves of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 6-10 are shown. It can be seen that all aerogels have good mechanical properties, which may be related to their honeycomb pore wall structures. The compressive strength of the chitosan-amyloid fiber aerogel in Comparative Example 1 is the smallest. As the concentration of citral increases, the compressive stress of the aerogel gradually increases. The maximum compressive strength of the aerogel increases from 595KPa in Comparative Example 1 to 1005KPa in Example 10, an increase of 68.9%. This confirms that citral grafting can further improve the mechanical properties of chitosan-amyloid fiber aerogels. The increase in the density of chitosan-amyloid fiber aerogels and the increase in cell wall thickness caused by citral grafting may be the main contributors to this event. It is worth noting that when the concentration of citral exceeds 2% (w / v), the compressive stress of the aerogel does not increase significantly, indicating the limited ability of citral to improve the mechanical properties of the material.
[0135] Figure 8 The water contact angle (WCA) of the chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10 is shown. It can be seen that the water contact angle of the chitosan-amyloid fiber aerogel in Comparative Example 1 is 0°, which is mainly attributed to the presence of a large number of hydrophilic groups in its network. After citral grafting, the water contact angle of the aerogel increased significantly (67.0-121.9°), which may be attributed to the anchoring of low polar groups (alkane chains) on the surface of the chitosan-amyloid fiber aerogel and the consumption of hydrophilic amino groups, and at the same time indicates the successful grafting of citral. When the citral concentration is lower than 1.5%, the water contact angle of the chitosan-amyloid fiber aerogel of Examples 6-7 does not exceed 90°, and still shows hydrophilicity, which may be attributed to the lower citral grafting density, and the original hydrophilic groups are still dominant. As the citral concentration increases further, the WCA of the aerogel of Example 5 reaches 121.9°, indicating a higher citral grafting density.
[0136] Fig. 9 The expansion rates of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 6-10 are shown. It can be seen that the chitosan-amyloid fiber aerogel in Comparative Example 1 has the highest water expansion rate, which is 26.42 g / g, which is attributed to the fact that a large number of hydrophilic groups in the aerogel retain water molecules in its network structure through hydrogen bonding. Despite this, the volume of the aerogel did not change significantly before and after water absorption, and the structure remained stable. After citral grafting, the chitosan-amyloid fiber expansion rates of Examples 6-10 were greatly reduced, and the aerogel expansion rate of Example 10 was as low as 7.81 g / g, less than 30% of the aerogel in Comparative Example 1, indicating good structural stability in water. And as the citral grafting rate increases, this change is more significant. This may be attributed to the low polarity alkane chain hindering the diffusion of water into the aerogel. Another possible reason is that citral grafting may make the aerogel have higher rigidity, limit the deformability of the polymer network, and thus reduce the water expansion rate.
[0137] Fig.10 The thermal stability of the chitosan-amyloid fiber aerogel in Comparative Example 1 and Examples 6-10 is shown. It can be seen that the weight loss process of the chitosan-amyloid fiber aerogel in Comparative Example 1 is mainly divided into three steps. The first step occurs in the temperature range of 30-218°C, with a weight loss of 22.09%, which is related to the strong hydrophilicity of the aerogel in Comparative Example 1. The first step can be divided into two stages: the first stage (30-120°C) is attributed to the loss of free water and water connected by hydrogen bonds in the sample; the second stage is attributed to the release of water more tightly connected by polar interactions with carboxylic acid groups. The second step occurs in the temperature range of 218-300°C, with a weight loss of 22.51%, which may be attributed to the depolymerization of the polymer network structure, hydroxyl decomposition and chitosan deacetylation. Next, a weight loss of 29.41% occurs between 300-500°C, corresponding to the carbonization of proteins and polysaccharides. Compared with the aerogel of Comparative Example 1, the moisture loss of the aerogels of Examples 6-10 between 30-120°C was 8.73-11.87%, depending on the citral concentration, which was significantly lower than the moisture loss of the aerogel sample of Comparative Example 1. This may be related to the good hydrophobic properties of the aldehyde-functionalized chitosan-amyloid fiber aerogel, and as the citral concentration increases, the hydrophobicity increases, resulting in a decrease in the residual moisture on the surface and inside of the aerogel. This is consistent with the contact angle analysis results. Fig.10 b. It can be observed that the initial decomposition temperature of the aerogels of Examples 6-10 is about 185°C, which is lower than 218°C of Comparative Example 1, indicating that citral grafting causes the thermal stability of the aerogels to be slightly weakened. Nevertheless, the aerogel samples of Examples 6-10 can still remain stable at temperatures up to nearly 200°C.
[0138] Fig.11The dibutyl phthalate removal efficiency of chitosan-amyloid fiber aerogels in Comparative Example 1 and Examples 6-10 is shown. It can be seen that the aerogel of Comparative Example 1 has the lowest dibutyl phthalate removal efficiency, which may be attributed to weaker hydrophobic interactions, indicating that citral grafting is an effective strategy to improve PAEs affinity. The aerogels of Examples 6-10 show different removal efficiencies for dibutyl phthalate, among which Example 8 has the highest removal efficiency, which may be attributed to its higher citral grafting amount and suitable hydrophobic properties.
[0139] Fig.12 The figure shows the removal efficiencies of different PAEs of the chitosan-amyloid fiber aerogel in Example 8. It can be seen that due to the rich functional groups and a large number of adsorption sites on the surface of the aerogel, and the high affinity for PAEs caused by citral grafting, the aerogel can adsorb PAEs through hydrogen bonds, Π-Π stacking and hydrophobic interactions, and shows good removal efficiency for dibutyl phthalate, diisobutyl phthalate, dipentyl phthalate, dihexyl phthalate, dioctyl phthalate, di(2-ethylhexyl) phthalate and butyl phthalate.
[0140] The embodiments provided above are not intended to limit the scope of the present invention, and the steps described are not intended to limit the execution order thereof. Those skilled in the art may make obvious improvements to the present invention in combination with existing common knowledge, which also fall within the scope of protection defined by the claims of the present invention.
Claims
1. A method for preparing natural aldehyde functionalized all-biomass aerogel, characterized in that: The steps include: (1) dispersing chitosan in an amyloid fiber solution and stirring to obtain a uniform mixed solution; (2) adding genipin as a cross-linking agent to the mixed solution obtained in step (1), heating and stirring for a period of time to obtain an aerogel precursor solution, and allowing it to stand for cross-linking to obtain a hydrogel; (3) freezing the hydrogel obtained in step (2), and then freeze-drying to obtain an aerogel; (4) The aerogel obtained in step (3) is immersed in a natural aldehyde solution for grafting modification, then taken out for rinsing, and then dried to obtain the aldehyde functionalized aerogel.
2. The preparation method according to claim 1, characterized in that The method for preparing the amyloid fibers described in step (1) comprises the following steps: S1. Purification of whey protein isolate: adding protein powder to water, stirring to obtain a protein dispersion, adjusting the pH of the protein dispersion to 4-5, centrifuging to obtain a supernatant, passing the supernatant through a 0.4-0.5 μm water filter membrane, and freeze-drying the filtrate to obtain purified protein; S2. Preparation of amyloid fibers: purified protein powder is dispersed in water, the obtained protein solution is stirred, and the pH of the protein solution is adjusted to 2-2.5, and then stirred and dried to obtain whey protein isolate amyloid fibers.
3. The preparation method according to claim 2, characterized in that: The protein powder in step S1 is whey protein isolate.
4. The preparation method according to claim 2, characterized in that: In step S1, the protein powder concentration of the protein dispersion is 5-15wt%; the stirring is performed at a speed of 100-1000 rpm for 8-12 hours; and the centrifugation is performed at 8000-10000×g for 20-30 minutes.
5. The preparation method according to claim 2, characterized in that: In step S2, the concentration of the purified protein powder in the protein solution is 1-5 wt%; the stirring is performed at 70-90°C at a speed of 100-1000 rpm for 8-12 hours.
6. The preparation method according to claim 1, characterized in that: In step (1), the concentration of amyloid fibers in the amyloid fiber solution is 1-1.25%, w / v; and the amyloid fiber solution contains 1-2 wt% of acetic acid.
7. The preparation method according to claim 1, characterized in that: In step (1), the mass ratio of chitosan to amyloid fiber is 1.5-2.5:
1.
8. The preparation method according to claim 1, characterized in that: In step (2), genipin is added in the form of genipin ethanol solution; the concentration of genipin in the genipin ethanol solution is 5-15%, w / v; the ratio of the mass of genipin added to the mass of chitosan in step (1) is 1:15-25.
9. The preparation method according to claim 1, characterized in that: In step (2), the heating temperature is 45-55°C; the heating time is 15-30 min; the static cross-linking temperature is 20-25°C; and the static cross-linking time is 24-32 h.
10. The preparation method according to claim 1, characterized in that: The freezing temperature in step (3) is -20 to -10°C and the freezing time is 15 to 30 hours.
11. The preparation method according to claim 1, characterized in that: The freeze-drying pressure in step (3) is 1-10 Pa, the temperature is -50 to -60° C., and the time is 60 to 72 h.
12. The preparation method according to claim 1, characterized in that: The natural aldehyde in step (4) includes one or more of citral, citronellal, cinnamaldehyde, p-anisaldehyde, and trans-2-hexenal.
13. The preparation method according to claim 1, characterized in that: In step (4), the natural aldehyde is citral.
14. The preparation method according to claim 1, characterized in that: The solvent of the natural aldehyde solution in step (4) is anhydrous ethanol; the concentration of the natural aldehyde in the natural aldehyde solution is 1.5-1.75%, w / v.
15. The preparation method according to claim 1, characterized in that: The temperature of the grafting modification in step (4) is 60-70°C and the time is 10-12h.
16. The preparation method according to claim 1, characterized in that: In step (4), the elution is performed using anhydrous ethanol.
17. A natural aldehyde functionalized all-biomass aerogel, characterized in that: The natural aldehyde functionalized all-biomass aerogel is prepared according to the preparation method according to any one of claims 1 to 16.
18. Application of the natural aldehyde functionalized all-biomass aerogel as claimed in claim 17 in the field of environmental protection or food processing.
Citation Information
Patent Citations
Egg preservation whey protein self-assembly fiber coating agent and application method thereof
CN103444839A
Method for enhancing functional characteristics of soybean amyloid protein fiber hydrogel by using food polyphenol
CN113575752A
Preparation method and application of super-hydrophobic aerogel with both ultrafast oil adsorption capacity and high compression recovery performance
CN115282888A
Amyloid fiber-ferulic acid-chitosan double-network hydrogel as well as preparation method and application thereof
CN115353646A
Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20110052695A1
Cited By
Preparation method and application of long-acting antibacterial fiber functional feed
CN119732438A
Fragrance-carrying porous material based on high internal phase emulsion template method as well as preparation method and application thereof
CN122427738A
Natural aldehyde-functionalized all-biomass aerogel and preparation method thereof
WO2026031835A1
